| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Amgen Inc COM(AMGN) | 79,246 | $21.3M | 7.17% |
| 2 | Incyte Corp Inc COM(INCY) | 358,454 | $20.7M | 6.97% |
| 3 | Gilead Sciences Inc Commo(GILD) | 233,584 | $17.5M | 5.90% |
| 4 | Intra-Cellular Therapies(ITCIEUR) | 317,856 | $16.5M | 5.57% |
| 5 | Biomarin Pharmaceutical I(BMRN) | 153,656 | $13.6M | 4.58% |
| 6 | Supernus Pharmaceuticals(SUPN) | 426,500 | $11.8M | 3.96% |
| 7 | Vera Therapeutics(VERA) | 758,355 | $10.4M | 3.50% |
| 8 | Biogen Inc Common Stock(BIIB) | 40,200 | $10.3M | 3.48% |
| 9 | Harmony Biosciences Holdi(HRMY) | 314,500 | $10.3M | 3.47% |
| 10 | Mirati Therapeutics Inc C(MRTXEUR) | 216,000 | $9.4M | 3.17% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 84.92% | 81.52% | -3.4% |
| Unclassified | 15.08% | 18.48% | +3.4% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Large Cap | 44.83% | 44.78% | -0.05% |
| Mid Cap | 27.7% | 20.33% | -7.37% |
| Unclassified | 15.08% | 18.48% | +3.4% |
| Small Cap | 12.39% | 15.35% | +2.96% |
| Mega Cap | 0% | 1.06% | +1.06% |
Quarter-over-quarter position changes